GANX Stock Ownership Activity
GAIN THERAPEUTICS INC 13F holders
No value investing guru has made any change to the GAIN THERAPEUTICS INC (GANX) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying GANX now?
According to the latest SEC filing(s) GAIN THERAPEUTICS INC (GANX) has not been purchased by any super investor.
To see more about who is investing in GAIN THERAPEUTICS INC (GANX), please go to the GANX ownership page.
2023 Q3
(1 result)
Current price: $3.03
7.62%
Reported price*: $3.28
2021 Q1
(1 result)
Current price: $3.03
79.69%
Reported price*: $14.92
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.